LIFE: the cash flow

MyFinsight

For the year ending 2025-12-31, LIFE had $56,043K increase in cash & cash equivalents over the period. $34,734K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-12-31
Net income	71,151
Total deferred expense	4,622
Depreciation and amortization	5,359
Non-cash interest expense	3,170
Accretion (amortization) of discounts and premium, investments	1,211
Stock-based compensation expense	10,596
Operating lease right-of-use asset amortization	903
Unrealized foreign currency translation	303
Prepaid and other assets	21,350
Accounts payable	30,631
Accounts receivable	11,195
Commissions receivable	13,707
Long-term commissions receivable	51,123
Accrued expenses	18,920
Other current liabilities	-8,738
Other long-term liabilities	-1,500
Net cash provided by (used in) operating activities	36,225
Purchase of property and equipment	1,491
Purchase of domain name	500
Purchase of investments	66,709
Proceeds from maturity of investments	99,870
Sales of investments	4,983
Investment in software development costs	4,286
Net cash provided by (used in) investing activities	31,867
Proceeds from liabilities related to sale of commissions receivable	5,000
Repayment of liabilities related to sale of commissions receivable	11,952
Proceeds from exercise of stock options and warrants	1,058
Payment of deferred offering costs	6,155
Net cash provided by (used in) financing activities	-12,049
Net increase in cash and cash equivalents	56,043
Effect of exchange rates on cash	-27
Cash and cash equivalents, beginning of year	35,075
Cash and cash equivalents, end of period	91,091

Unit: Thousand (K) dollars